Sens. Lamar Alexander (R-TN) and Patty Murray (D-WA) yesterday formally introduced a , which has 11 Republican and 11 Democrat , intended to stabilize the Health Insurance Marketplaces authorized by the Affordable Care Act. The bill would provide short-term funding for the cost-sharing reductions; expand access to lower-cost, catastrophic health plans; give states additional flexibility to use 1332 waivers; provide states with outreach and education funding; and direct the Department of Health and Human Services to issue regulations facilitating the sale of insurance products across state lines. The bill has not yet been scored by the Congressional Budget Office and would require 60 votes in the Senate to move forward. The AHA and seven other national organizations today thanked Alexander and Murray for their leadership and urged 鈥淐ongress to take action to enact legislation that includes continued funding for CSR benefits for the rest of 2017 and for at least the next two years (2018-2019).鈥 In addition to AHA, the statement鈥檚 signers include America鈥檚 Health Insurance Plans, American Academy of Family Physicians, American Benefits Council, American Medical Association, Blue Cross Blue Shield Association, Federation of 黑料正能量s, and U.S. Chamber of Commerce.

Related News Articles

Headline
The House Budget Committee May 16 voted 21-16 against advancing the fiscal year 2025 budget reconciliation bill, with five Republicans joining all Democrats in鈥
Headline
The AHA May 16 urged the Department of Commerce to consider tariff exceptions for critical minerals and derivative products used for medical purposes. Critical鈥
Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B 鈥渞ebate鈥
Headline
The Administration for Strategic Preparedness and Response May 15 announced it is launching four pharmaceutical manufacturing projects using artificial鈥
Headline
There have been 1,024 confirmed cases of measles across the U.S. so far in 2025, according to the latest data from the Centers for Disease Control and鈥
Headline
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer鈥檚 disease. The test, created by Fujirebio Diagnostics,鈥